细胞因子和趋化因子对阿尔茨海默病的特征性病理改变的影响

Title:Impact of Cytokines and Chemokines on Alzheimer’s Disease Neuropathological Hallmarks

Volume: 14 Issue: 8

关键词: 炎症反应、细胞因子、趋化因子、淀粉样前体蛋白，β-淀粉样蛋白，tau蛋白

摘要: Background: Alzheimer’s disease (AD) is the most common neurodegenerative disorder, neuropathologically characterized by aggregates of β-amyloid peptides, which deposit as senile plaques, and of TAU protein, which forms neurofibrillary tangles. It is now widely accepted that neuroinflammation is implicated in AD pathogenesis.

Method: Indeed, inflammatory mediators, such as cytokines and chemokines (chemotactic cytokines) can impact on the Alzheimer´s amyloid precursor protein by affecting its expression levels and amyloidogenic processing and/or β -amyloid aggregation. Additionally, cytokines and chemokines can influence kinases’ activities, leading to abnormal TAU phosphorylation. To date there is no cure for AD, but several therapeutic strategies have been directed to prevent neuroinflammation. Anti-inflammatory, but also anti-amyloidogenic compounds, such as flavonoids were shown to favourably modulate some pathological events associated with neurodegeneration.

Conclusion: This review focuses on the role of cytokines and chemokines in AD-associated pathologies, and summarizes the potential anti-inflammatory therapeutic approaches aimed at preventing or slowing down disease progression.

Cite this article as:

Impact of Cytokines and Chemokines on Alzheimer’s Disease Neuropathological Hallmarks, Current Alzheimer Research 2017; 14 (8) . https://dx.doi.org/10.2174/1567205014666170317113606

DOI https://dx.doi.org/10.2174/1567205014666170317113606	Print ISSN 1567-2050
Publisher Name Bentham Science Publisher	Online ISSN 1875-5828